How to manage HIV-infected patients with chronic kidney disease in the HAART era. - Wikidata - awgldk - TriplyDB

How to manage HIV-infected patients with chronic kidney disease in the HAART era.

How to manage HIV-infected patients with chronic kidney disease in the HAART era.

http://www.wikidata.org/entity/Q37980388

about

A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection.Protease Inhibitors and Renal Function in Patients with HIV Infection: a Systematic Review.Atazanavir nephrotoxicity.Renal Function in Chinese HIV-Positive Individuals following Initiation of Antiretroviral Therapy.Elevation of Non-Classical (CD14+/lowCD16++) Monocytes Is Associated with Increased Albuminuria and Urine TGF-β1 in HIV-Infected Individuals on Stable Antiretroviral Therapy.A National Study of Outcomes among HIV-Infected Kidney Transplant Recipients Exploratory Analysis for the Evaluation of Estimated Glomerular Filtration Rate, Cholesterol and Triglycerides after Switching from Tenofovir/Emtricitabine plus Atazanavir/Ritonavir (ATV/r) to Abacavir/Lamivudine plus ATV/r in Patients with Preserve The case of chronic hepatitis B treatment with tenofovir: an update for nephrologists.Survival Benefit of Kidney Transplantation in HIV-infected Patients.The Aging Population with HIV Infection.Renal abnormalities in a cohort of HIV-infected children and adolescents.Healthcare utilization and direct costs of non-infectious comorbidities in HIV-infected patients in the USA.Association between tenofovir exposure and reduced kidney function in a cohort of HIV-positive patients: results from 10 years of follow-up.

P2860

Q35149475-170F11E4-E9A7-45B1-BD19-E4904FB902F7 Q35186842-425D307E-A1D7-4F23-B3C3-B44807AC4656 Q35207867-8B995B3D-0057-47F3-9084-ACE94C595C22 Q35758954-C6E6C3F6-A661-4F2A-8A2B-AED16D54CFDA Q35994939-7E50A5EF-989C-4053-B37A-034B5C921FA7 Q36003147-D32AE250-8997-41D4-A81C-A75658B1ACAA Q37141511-87163280-C559-49AE-BE44-319569D8C7D9 Q38520954-A33DBADA-726F-46FB-A6CD-0B5D8E49C04A Q39262004-89B45084-F809-4035-A95C-E9B9CCEF6C49 Q40101352-4E8A468F-F437-4ECC-9BD8-DD062C5E6AF0 Q40882714-A5C1D006-9BAD-4C19-A282-6BE237E5A8B7 Q41995759-33129944-A6CC-4DF4-AE18-90295DEDD41F Q45400742-B7013F36-5C58-41CC-9789-8B3498796AC7

P2860

How to manage HIV-infected patients with chronic kidney disease in the HAART era.

http://www.wikidata.org/entity/Q37980388

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

How to manage HIV-infected patients with chronic kidney disease in the HAART era.

@en

How to manage HIV-infected patients with chronic kidney disease in the HAART era.

@nl

type

label

How to manage HIV-infected patients with chronic kidney disease in the HAART era.

@en

How to manage HIV-infected patients with chronic kidney disease in the HAART era.

@nl

prefLabel

How to manage HIV-infected patients with chronic kidney disease in the HAART era.

@en

How to manage HIV-infected patients with chronic kidney disease in the HAART era.

@nl

P1433

Q37980388-BE5978EF-3962-484E-9A07-2FF601EB4E31

P1476

Q37980388-D5F9A10D-081F-4E41-BC10-209D1901CDD0

P2093

Q37980388-8C1E4C06-1F08-4180-9E3A-E1BEAFB477CF

Q37980388-EC8205CF-1596-40D2-A892-9DE961B1AEEE

Q37980388-F42BB5BD-10A5-47FA-82C3-C5CDFC2EDC83

P2860

Q37980388-00143AC9-5600-4A7E-87FB-D1AACCA32911

Q37980388-05D4EE9E-53D4-4FDD-9068-1516877A5364

Q37980388-0A8B971F-7C42-42A3-AF60-806445B5ECB9

Q37980388-0B182F09-AB16-42AE-BEC5-0099A06CAD1E

Q37980388-0EC2A867-50A6-4483-A145-08EB21FA4BDA

Q37980388-1915C092-EA83-4825-A1E5-52A16FE42575

Q37980388-1C3C86E0-CB96-420C-9553-AD0868821E06

Q37980388-1DC10840-5490-4553-A3B1-8F67D0DA91D5

Q37980388-2796EB2A-48A1-4416-831D-2AD1EEDE9ABA

Q37980388-2A3A1D93-4C51-4128-9837-AF74C33A96C7

P2888

Q37980388-7877C049-A3B0-4332-9B78-CB165BFA4970

P304

Q37980388-EDDCB5C5-2AB4-44B0-AE2F-E5F7C0245D8A

P31

Q37980388-5288E4C9-4433-4508-B4F5-6AEE001A3338

P356

Q37980388-405D2CD8-B470-4454-8B24-11AFD6F471B5

P433

Q37980388-151E798B-35F1-4B5C-B03B-9F170F160E6F

P478

Q37980388-9E942466-031E-422C-AFDC-4BAA248C1D0B

P577

Q37980388-D8055F2A-F4B9-4141-A842-427CDE6E51E4

P698

Q37980388-752CE064-BBD1-4453-A72A-E73FB1BD5B95

P356

S10157-012-0585-7

P1433

Clinical and experimental nephrology

P1476

How to manage HIV-infected patients with chronic kidney disease in the HAART era.

@en

P2093

Ken Tsuchiya

http://www.w3.org/2001/XMLSchema#string

Kosaku Nitta

http://www.w3.org/2001/XMLSchema#string

Minoru Ando

http://www.w3.org/2001/XMLSchema#string

P2860

Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study

A new equation to estimate glomerular filtration rate

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD

Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement

Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III)

Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy

Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy.

Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study.

Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients.

Decline in the AIDS and death rates in the EuroSIDA study: an observational study.

P2888

s10157-012-0585-7

P304

363-372

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10157-012-0585-7

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22294158

http://www.w3.org/2001/XMLSchema#string